Westpac Banking Corp increased its position in McKesson Co. (NYSE:MCK) by 38.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 123,962 shares of the company’s stock after purchasing an additional 34,620 shares during the period. Westpac Banking Corp owned approximately 0.06% of McKesson worth $16,444,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of MCK. Fort L.P. bought a new position in shares of McKesson in the 2nd quarter worth $110,000. Flagship Harbor Advisors LLC bought a new position in McKesson during the 2nd quarter valued at $118,000. Reilly Financial Advisors LLC lifted its stake in McKesson by 506.8% during the 3rd quarter. Reilly Financial Advisors LLC now owns 898 shares of the company’s stock valued at $119,000 after acquiring an additional 750 shares in the last quarter. Bray Capital Advisors bought a new position in McKesson during the 3rd quarter valued at $123,000. Finally, FNY Investment Advisers LLC lifted its stake in McKesson by 88.6% during the 3rd quarter. FNY Investment Advisers LLC now owns 1,120 shares of the company’s stock valued at $148,000 after acquiring an additional 526 shares in the last quarter. Institutional investors own 89.97% of the company’s stock.
In other news, Director N Anthony Coles sold 1,350 shares of the firm’s stock in a transaction on Friday, August 31st. The stock was sold at an average price of $128.69, for a total transaction of $173,731.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.87% of the company’s stock.
Shares of McKesson stock opened at $121.16 on Monday. McKesson Co. has a 1 year low of $117.19 and a 1 year high of $178.86. The firm has a market cap of $23.67 billion, a PE ratio of 9.60, a price-to-earnings-growth ratio of 1.38 and a beta of 1.05. The company has a quick ratio of 0.56, a current ratio of 0.99 and a debt-to-equity ratio of 0.69.
McKesson (NYSE:MCK) last announced its earnings results on Thursday, October 25th. The company reported $3.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.28 by $0.32. McKesson had a return on equity of 26.55% and a net margin of 0.06%. The firm had revenue of $53.08 billion during the quarter, compared to analyst estimates of $53.56 billion. Equities analysts expect that McKesson Co. will post 13.41 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 2nd. Stockholders of record on Monday, December 3rd will be given a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 1.29%. The ex-dividend date is Friday, November 30th. McKesson’s dividend payout ratio is presently 12.36%.
TRADEMARK VIOLATION NOTICE: “Westpac Banking Corp Purchases 34,620 Shares of McKesson Co. (MCK)” was first posted by WKRB News and is the sole property of of WKRB News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.wkrb13.com/2018/11/26/westpac-banking-corp-purchases-34620-shares-of-mckesson-co-mck.html.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Recommended Story: Understanding the different types of bonds
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.